Atlas Trials

A Bioequivalence Study Testing Two Formulations of Sotagliflozin in Healthy Male and Female Subjects Under Fasted Conditions

Clinical trial NCT03776227 · COMPLETED

Trial details

NCT number
NCT03776227
Sponsor
Sanofi
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Type 2 Diabetes MellitusHealthy Subjects
Start date
2019-01-25
Primary completion
2019-04-22
Enrollment
66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.